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Background
Cardiovascular magnetic resonance (CMR) is an excel-
lent non invasive method for lifelong post HTX staging,
feasible to identify patients with an acute cellular rejec-
tion (ACR). This study evaluates the diagnostic perfor-
mance of T1- and T2-Mapping CMR to identify biopsy
proven acute cellular rejection (ACR) in comparison to
conventional CMR techniques.
Methods
Thirty-five CMRs were performed (mean age 53±11
years, 24male) using a 1.5T scanner (Achieva, Philips
medical systems, Best, The Netherlands) compared to
EMB. The CMR-protocol included conventional
sequences to assess myocardial edema ratio (ER), a
T1-weighted spinecho sequence for global relative
enhancement (gRE) and inversion recovery sequences to
visualize late gadolinium enhancement (LE). Histological
grading according to the International Society for Heart
and Lung Transplantation (ISHLT) from 1990, in which
grade ≥1B was considered as a clinically relevant ACR,
which has to be treated.
T1-quantification was performed using the modified
Look-Locker inversion-recovery (MOLLI) sequence before
and 15 minutes after administration of 0.1 mmol/kg body
weight of Gadobutrol (Gadovist, Bayer HealthCare, Berlin,
Germany). T2-quantification was performed using a free-
breathing, navigator-gated multi-echo-sequence. Global
myocardial T1 pre- and post-contrast, T2 and ECV maps
were calculated with a dedicated Software (cvi42).
Results
In 20/35 (57%) EMBs there was no or mild ACR
(ISHLT 0A, 1A) and a clinically relevant ACR in 15/35
EMBs (1B, 2A, 4A).
The best Receiver Operating Characteristics (ROC) with
high values for the area-under-the-curve (AUC) - to discri-
minate between relevant and non-relevant ACR - were
demonstrated by postcontrast myocardial T1-mapping
(0.78), myocardial T2-mapping (0.73) and native myocar-
dial T1-mapping (0.65), respectively. Comparable results
were achieved with the calculated value of the extracellular
volume (ECV) with 0.66. The conventional CMR techni-
ques ER and gRE revealed only moderate results with 0.54
and 0.52, respectively. Similar to myocarditis the critical
values for ER were ≥2 and ≥4.5 for the gRE.
Accordingly, the best sensitivity and specificity for
clinically relevant ACR ≥1B could be achieved with
postcontrast T1-mapping using a cut off-value of 342ms
(73%/70%) and T2-mapping using a cut off value of
65ms (73%/75%), respectively. Again comparable results
could be achieved with the ECV using a cut off of
42 (67%/70%) and moderate results by using native T1-
mapping with a cut off of 1060 ms (87%/45%).
Conclusions
Parametric CMR is encouraging to identify subclinical
ACR in patients after HTx, especially postcontrast T1-
and T2-mapping. However, larger studies are needed to
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